Singapore markets closed

Straits Times Index
3,307.90
-6.15(-0.19%)
S&P 500
5,312.85
+4.72(+0.09%)
Dow
39,867.84
+61.07(+0.15%)
Nasdaq
16,790.30
-4.58(-0.03%)
Bitcoin USD
70,761.65
+3,993.72(+5.98%)
CMC Crypto 200
1,532.39
+43.85(+2.94%)

BCRX Jan 2025 27.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.0500

0.0000

(0.00%)

As of 03:00PM EDT. Market open.

Loading interactive chart…

GuruFocus.com
Insider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
Helen Thackray, Chief Research & Development Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 14, 2024.
GuruFocus.com
Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
On May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21,940 shares of the company, as reported in a recent SEC Filing.
GuruFocus.com
Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
Charles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 13, 2024.